Corneal Stromal Regeneration: A Review of Human Clinical Studies in Keratoconus Treatment

Mona El Zarif, Jorge L Alió, Jorge L Alió Del Barrio, Maria P De Miguel, Karim Abdul Jawad, Nehman Makdissy, Mona El Zarif, Jorge L Alió, Jorge L Alió Del Barrio, Maria P De Miguel, Karim Abdul Jawad, Nehman Makdissy

Abstract

The use of advanced therapies with stem cells to reconstruct the complex tissue of corneal stroma has gained interest in recent years. Besides, collagen-based scaffolds bioengineering has been offered as another alternative over the last decade. The outcomes of the first clinical experience with stem cells therapy on corneal stroma regeneration in patients with advanced keratoconus were recently reported. Patients were distributed into three experimental groups: Group 1 (G-1) patients underwent implantation of autologous adipose-derived adult stem cells (ADASCs) alone, Group 2 (G-2) received a 120 μm decellularized donor corneal stromal laminas, and Group 3 (G-3) received a 120 μm recellularized donor laminas with ADASCs. A follow up of 36 months of clinical data, and 12 months of confocal microscopy study was performed, the authors found significant clinical improvement in almost all studied mean values of primary and secondary outcomes. Corneal confocal microscopy demonstrated an increase in cell density in the host stroma, as well as in the implanted tissue. Using different approaches, allogenic small incision lenticule extraction (SMILE) implantation was applied in cases with advanced keratoconus. Some authors reported the implantation of SMILE intrastromal lenticules combined with accelerated collagen cross-linking. Others performed intrastromal implantation of negative meniscus-shaped corneal stroma lenticules. Others have compared the outcomes of penetrating keratoplasty (PKP) vs. small-incision Intralase femtosecond (IFS) intracorneal concave lenticule implantation (SFII). Femtosecond laser-assisted small incision sutureless intrasotromal lamellar keratoplasty (SILK) has been also investigated. The published evidence shows that the implantation of autologous ADASCs, decellularized or recellularized human corneal stroma, allogenic SMILE lenticules corneal inlay, and recombinant cross-linked collagen have shown initially to be potentially effective for the treatment of advanced keratoconus. In light of the present evidence available, it can be said that the era of corneal stromal regeneration therapy has been already started.

Keywords: autologous adipose-derived adult stem cells; corneal bioengineering; corneal stem cell therapy; corneal surgery; cross-linked collagen; keratoconus; regenerative medicine; stem cells.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 El Zarif, Alió, Alió del Barrio, De Miguel, Abdul Jawad and Makdissy.

Figures

Figure 1
Figure 1
Cornea Visante optical coherence tomography images and pachymetric maps. (A) Preoperative OCT in case 1, G-1. (B) OCT at 12 months post-op of the same patient, notice the transparency of the cornea. (C) OCT at 36 months post-op with case 2, G-1. Observe the transparency of the cornea, the (yellow arrows) demonstrate the limit of the flap. (D) Preoperative OCT in case 7, G-2, Notice the highly reflective area in the corneal stroma (red arrow). (E,F) OCT at 12 months and 36 postoperative in case 7. The improvement of the reflective band of neo-collagen in the periphery of the implanted lamina (yellow arrows) can be seen. The reflectance of the neo-collagen band (red arrow) is higher at 12 months in the center of the implanted lamina. (G) Preoperative OCT in case 13, G-3. The reflective paracentral scars can be noticed (yellow arrow). (H,I) OCT at 12 and 36 months post-op. The high reflectance of the neo-collagen band (red arrow) can be seen more evident at 36 months with this patient in the center of the lamina. Notice the improvement of the preoperative paracentral scars at 36 months post-op (yellow arrows). (J) OCT in Case9, G-2, and (K) in Case 12, G-3 at 36 months post-op. (yellow arrows) shows the limits of the laminas.
Figure 2
Figure 2
Biomicroscopic changes between the preoperative up to 36 months post-operative. (A) G-1, case 4, OS, shows the transparency of the cornea in the preoperative. (B) G-1, case 4, shows the transparency of the cornea. The presence of a peripheral surgical scar (red arrow) at 1month post-op can be noticed. (C) G-1, case 4, shows the stability of the peripheral scaring (red arrow) in the cornea at 12 months post-op. (D) G-1, case 4, shows the transparency of the cornea at 36 months post-op. (E) G-2, case 9, OD, shows the presence of a slight paracentral scar( red arrows) at the pre-operative. (F) G-2, case 9, 12 months post-op, observe the improvement in the transparency of the implanted lamina, (red arrow) represent the periphery of the lamina. (G) G-2, case 9, 36 months post-op, notice the marked improvement in the transparency of the lamina, the periphery of the sheet becomes not very marked (red arrow). (H) G-3, case 12, OD, shows the transparency of the cornea in the preoperative. (I) G-3, case 12, 12 months post-op. The (red arrow) indicates the implanted recellularized lamina. (J) G-3, case 12, 36 months post-op. The (red arrow) indicates the periphery of the recellularized lamina. Notice the improvement of the transparency of the implanted tissue.
Figure 3
Figure 3
Shows statistical mean results after 3 years follow-up in G-1, G-2, and G-3, respectively (A) Shows an amelioration in CDVA (corrected distance visual acuity) (decimal), mean values in the pre-operatives were (0.40, 0.22, 0.21), at 12 months post-operatives mean values were (0.60, 0.42, 041) and (0.58, 0.40, 0.40) at 36 months post-operative. Desviation Standard = 0.151. (B) Shows an upgraded in CLDVA (decimal equivalent to logMar scale) from the pre-operative (0.61, 0.39, 0.52) until reach a maximum mean values at 36 months post-operative (0.84, 0.62, 0.75). Desviation Standard = 0.180. (C) Presents Visante CCT (central corneal thickness) (μm) mean values in the pre-operative (410, 454, 487) (μm), at 12 months post-operative, these values reached a maximum average (469, 513, 546) (μm), then at 36 months post-operative, they were established with the following average values (440, 484, 517) (μm). Desviation Standard = 62.940. (D) Presents the Scheimpflug corneal topography thinnest point (μm) mean values in the preop (385, 435, 449) (μm), there were an increase in the topographic mean values till 12 months post-operative (433, 484, 498) (μm), than at 36 months post-operative, a small decrease was obtained with this mean values (416, 466, 480) (μm). Desviation Standard = 67.966. (E) Observe the amelioration in RMS HOA (high order aberration in μm) in mean values at the pre-operative values (15.01, 10.11, 12.23), at 36 months post-operative (13.15, 8.25, 10.37). Desviation Standard = 4.530. (F) Observe Kmax , the pre-operative mean values (68, 68, 66), there was a mean values of 2 diopters more flatter at 12 months post-operative (66, 66, 64) regarding the preoperative, followed by another mean value of 1 diopter of flattening till 36 months post-operative (65, 65, 63). Desviation Standard = 8.250.
Figure 4
Figure 4
Corneal topography (Pentacam) comparison between preoperative, 12 and 36 months post-op. (A) Comparative paquimetric examinations (right side) among the preoperative (middle) and 12 months post-op (left side) in case 1, G-1. Observe the modest improvement of the corneal thickness (B) Preoperative (middle) and 12 months post-op (left side) sagittal curvature comparative exams (right side), in case 1, G-1. Notice the modest improvement in the keratometric parameters of the cornea. (C) Comparative paquimetric examinations (right side) among the preoperative (middle) and 12 months post-op (left side) in case 6, G-2. Observe the improvement of the corneal thickness. (D) Preoperative (middle) and 36 months post-op (left side) sagittal curvature comparative exam (right side), in case 6, G-2. Notice the improvement in the keratometric parameters of the cornea. (E) Sagittal curvature comparative exam (right side) among the preoperative (middle) and almost 3 years post-op (left side) in case 12, G-3. Enhancement of the keratometric parameters can be observed. (F) Comparison pachymetric exam (right side) among the preoperative (middle) and 3 years post-op (left side) in case 12, G-3. The markable enhancement of the paquimetric parameters can be noticed.
Figure 5
Figure 5
Corneal Aberrometry with case 5, G-2. (A,B) (Pentacam) Third-order aberration RMS 3rd order RMS (μm). Observe the improvement in mean values from the preoperative (10.356) (μm) till (7.924) (μm) at 36 months post-op. (C,D) (Pentacam) high order aberration RMS HOA RMS (μm). Notice the amelioration between the preoperative mean values (12.339) (μm) and 36 months post-op (8.451) (μm).
Figure 6
Figure 6
Confocal microscopy study with HRT3 RCM (Heidelberg). (A) Confocal microscopy of the anterior corneal stroma with case 1, G-1. Notice the few nuclear corneal cell density. (B) Nuclear cell density in the anterior stroma with case 1 at 12 months post-operative. Notice the increment of the cell density. (C) Acellular implanted lamina with case 5, G-2 at 1 month post-operative. (D) Recellularization of the anterior surface of the implanted decellularized lamina in the same case 5 at 12 months postoperative. (E) The posterior surface of the recellularized lamina with case 13, G-3 at 1 month after the operation: the presence of few ADASCs with similar morphology of keratocytes. (F) The posterior surface of the recellularized lamina with case 13 at 12 months after surgery: Observe the abundant number of stromal cells.

References

    1. Alió Del Barrio JL, El Zarif M, de Miguel MP, Azaar A, Makdissy N, Harb W, et al. . Cellular therapy with human autologous adipose-derived adult stem cells for advanced keratoconus. Cornea. (2017) 36:952–60. 10.1097/ICO.0000000000001228
    1. Alió JL, Piñero DP, Alesón A, Teus MA, Barraquer RI, Murta J, et al. . Keratoconus-integrated characterization considering anterior corneal aberrations, internal astigmatism, corneal biomechanics. J Cataract Refract Surg. (2011) 37:552–68. 10.1016/j.jcrs.2010.10.046
    1. Ruberti JW, Zieske JD. Prelude to corneal tissue engineering - gaining control of collagen organization. Prog Retin Eye Res. (2008) 27:549–77. 10.1016/j.preteyeres.2008.08.001
    1. Arnalich-Montiel F, Pastor S, Blazquez-Martinez J, Fernandez-Delgado A, Nistal M, Alio JL, et al. . Adipose-derived stem cells are a source for cell therapy of the corneal stroma. Stem Cells. (2008) 26:570–9. 10.1634/stemcells.2007-0653
    1. Espandar L, Bunnell B, Wang GY, Gregory P, McBride C, Moshirfar M. Adipose-derived stem cells on hyaluronic acid-derived scaffold: a new horizon in bioengineered cornea. Arch Ophthalmol. (2012) 130:202–8. 10.1001/archopthalmol.2011.1398
    1. Kao WWY, Coulson Thomas VJ. Cell therapy of corneal diseases. Cornea. (2016) 35(Suppl. 1):S9–19. 10.1097/ICO.0000000000001010
    1. De Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, Pascual CY, Aller MA, Arias J, et al. . Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med. (2012) 12:574–91. 10.2174/156652412800619950
    1. Lynch AP, Ahearne M. Strategies for developing decellularized corneal scaffolds. Exp Eye Res. (2013) 108:42–7. 10.1016/j.exer.2012.12.012
    1. De Miguel MP, Alio JL, Arnalich-Montiel F, Fuentes-Julian S, de Benito-Llopis F, Amparo L, et al. . Cornea and ocular surface treatment. Curr Stem Cell Res Ther. (2010) 5:195–204. 10.2174/157488810791268663
    1. Alió Del Barrio JL, El Zarif M, Azaar A, Makdissy N, Khalil C, Harb W, et al. . Corneal stroma enhancement with decellularized stromal laminas with or without stem cell recellularization for advanced keratoconus. Am J Ophthalmol. (2018) 186:47–58. 10.1016/j.ajo.2017.10.026
    1. Alió JL, Alió Del Barrio JL, El Zarif M, Azaar A, Makdissy N, Khalil C, et al. . Regenerative surgery of the corneal stroma for advanced keratoconus: 1-year outcomes. Am J Ophthalmol. (2019) 203:53–68. 10.1016/j.ajo.2019.02.009
    1. Alió JL, Alió del Barrio LJ. Cellular therapy with human autologous adipose-derived adult stem cells for advanced keratoconus: reply to the letter to editor. Cornea. (2017) 36:e37. 10.1097/ICO.0000000000001347
    1. El Zarif M, Abdul Jawad K, Alió del Barrio JL, Abdul Jawad Z, Palazón-Bru A, De Miguel MP, et al. . Corneal stroma cell density evolution in keratoconus corneas following the implantation of adipose mesenchymal stem cells and corneal laminas: an in vivo confocal microscopy study. IOVS. (2020) 61:22. 10.1167/iovs.61.4.22
    1. El Zarif M, Alió JL, Alió del Barrio JL, Abdul Jawad K, Palazón-Bru A, Abdul Jawad Z, et al. . Corneal stromal regeneration therapy for advanced keratoconus: long-term outcomes at 3 years. Cornea. (2020).
    1. Alió del Barrio J, Chiesa M, Ferrer GG, Garagorri N, Briz N, Fernandez-Delgado J, et al. . Biointegration of corneal macroporous membranes based on poly(ethyl acrylate) copolymers in an experimental animal model. J Biomed Mater Res A. (2015) 103:1106–18. 10.1002/jbm.a.35249
    1. Alió del Barrio J, Chiesa M, Garagorri N, Garcia-Urquia N, Fernandez-Delgado J, Bataille L, et al. . Acellular human corneal matrix sheets seeded with human adipose-derived mesenchymal stem cells integrate functionally in an experimental animal model. Exp Eye Res. (2015) 132:91–100.
    1. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. . Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. (2001) 7:211–28. 10.1089/107632701300062859
    1. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. . Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. (2002) 13:4279–95. 10.1091/mbc.e02-02-0105
    1. Arnalich-Montiel F, Alió Del Barrio JL, Alió JL. Corneal surgery in keratoconus: which type, which technique, which outcomes?” Eye Vis. (2016) 3:2. 10.1186/s40662-016-0033-y
    1. Ponce Márquez S, Martínez VS, McIntosh Ambrose W, Wang J, Gantxegui NG, Schein O, et al. . Decellularization of bovine corneas for tissue engineering applications. Acta Biomater. (2009) 5:1839–47. 10.1016/j.actbio.2009.02.011
    1. Guthoff R, Klink T, Schlunck G, Grehn F. Die sickerkissenuntersuchung mittels konfokaler in-vivo mikroskopie mit dem rostocker cornea modul - erste erfahrungen. Klin Monatsbl Augenheilkd. (2005) 222:R8. 10.1055/s-2005-922279
    1. Mastropasqua L, Nubile M. Normal corneal morphology. In: Mastropasqua L, Nubile M. editors. Confocal Microscopy of the Cornea. Thorofare, NJ: SLACK; (2002). p. 7–16.
    1. Ali Javadi M, Kanavi MR, Mahdavi M, Yaseri M, Rabiei HM, Javadi A, et al. . Comparison of keratocyte density between keratoconus, post-laser in situ keratomileusis keratectasia, and uncomplicated post-laser in situ keratomileusis cases. A Confocal Scan Study. Cornea. (2009) 28:774–9. 10.1097/ICO.0b013e3181aa265b
    1. Ku JYF, Niederer RL, Patel DV, Sherwin T, McGhee CN. Laser scanning in vivo confocal analysis of keratocyte density in keratoconus. Ophthalmology. (2008) 115:845–50. 10.1016/j.ophtha.2007.04.067
    1. Riau AK, Angunawela RI, Chaurasia SS, Lee WS, Tan DT, Mehta JS. Reversible femtosecond laser-assisted myopia correction: a non-human primate study of lenticule re-implantation after refractive lenticule extraction. PloS ONE. (2013) 8:e67058. 10.1371/journal.pone.0067058
    1. Angunawela RI, Riau AK, Chaurasia SS, Tan DT, Mehta JS. Refractive lenticule re-implantation after myopic relex: a feasibility study of stromal restoration after refractive surgery in a rabbit model. Investig Ophthalmol Vis Sci. (2012) 53:4975–85. 10.1167/iovs.12-10170
    1. Jacob S, Kumar DA, Agarwal A, Agarwal A, Boptom AR, Saijimol AI. Preliminary evidence of successful near vision enhancement with a new technique: PrEsbyopic Allogenic Refractive Lenticule. (PEARL) corneal inlay using a SMILE lenticule. J Refract Surg. (2017) 33:224–9. 10.3928/1081597X-20170111-03
    1. Ganesh S, Brar S, Rao PA. Cryopreservation of extracted corneal lenticules after small incision lenticule extraction for potential use in human subjects. Cornea. (2014) 33:1355–62. 10.1097/ICO.0000000000000276
    1. Ganesh S, Brar S. Femtosecond intrastromal lenticular implantation combined with accelerated collagen cross-linking for the treatment of keratoconus– initial clinical result in 6 eyes. Cornea. (2015) 34:1331–9. 10.1097/ICO.0000000000000539
    1. Mastropasqua L, Nubile M. Corneal thickening and central flattening induced by femtosecond laser hyperopic-shaped intrastromal lenticule implantation. Int Ophthalmol. (2017) 37:893–904. 10.1007/s10792-016-0349-6
    1. Mastropasqua L, Nubile M, Salgari N, Mastropasqua R. Femtosecond laser-assisted stromal lenticule addition keratoplasty for the treatment of advanced keratoconus: a preliminary study. J Refract Surg. (2018) 34:36–44. 10.3928/1081597X-20171004-04
    1. Jin H, Liu L, Ding H, He M, Zhang C, Zhong X. Comparison of femtosecond laser-assisted corneal intrastromal xenotransplantation and the allotransplantation in rhesus monkeys. BMC Ophthalmol. (2017) 17:202. 10.1186/s12886-017-0595-z
    1. Jin H, He M, Liu H, Zhong X, Wu J, Liu L, et al. . Small-incision femtosecond laser–assisted intracorneal concave lenticule implantation in patients with keratoconus. Cornea. (2019) 38:446–53. 10.1097/ICO.0000000000001877
    1. Pradhan KR, Reinstein DZ, Vida RS, Archer TJ, Dhungel S, Moptom D, et al. . Femtosecond laser–assisted small incision Sutureless Intrastromal Lamellar Keratoplasty (SILK) for corneal transplantation in keratoconus. J Refract Surg. (2019) 35:663–71. 10.3928/1081597X-20190826-01
    1. Gahmberg CG, Fagerholm SC, Nurmi SM, Chavakis T, Marchesan SI, Grönholm M. Regulation of integrin activity and signalling. Biochim Biophys Acta. (2009) 1790:431–44. 10.1016/j.bbagen.2009.03.007
    1. Fagerholm P, Lagali NS, Merrett K, Jackson WB, Munger R, Liu Y, et al. . A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study. Sci Transl Med. (2010) 2:46ra61. 10.1126/scitranslmed.3001022
    1. Fagerholm P, Lagali NS, Ong J, Merrett K, Jackson WB, Polarek JW, et al. . Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold. Biomaterials. (2014) 35:2420–7. 10.1016/j.biomaterials.2013.11.079
    1. Ong JA, Auvinet E, Forget KJ, Lagali N, Fagerholm P, Griffith M, et al. . 3D Corneal shape after implantation of a biosynthetic corneal stromal substitute. Invest Ophthalmol Vis Sci. (2016) 57:2355–65. 10.1167/iovs.15-18271
    1. Doroodgar F, Jabbarvand M, Niazi S, Karimian F, Niazi F, Sanginabadi A, et al. . Customized stromal lenticule implantation for keratoconus. J Refract Surg. (2020) 36:786–94. 10.3928/1081597X-20201005-01
    1. Pradhan KR, Reinstein DZ, Carp GI, Archer TJ, Gobbe M, Gurung R. Femtosecond laser-assisted keyhole endokeratophakia: correction of hyperopia by implantation of an allogeneic lenticule obtained by SMILE from a myopic donor. J Refract Surg. (2013) 29:777–82. 10.3928/1081597X-20131021-07
    1. Sekundo W, Kunert KS, Blum M. Small incision corneal refractive surgery using the Small Incision Lenticule Extraction. (SMILE) procedure for the correction of myopia and myopic astigmatism: results of a 6 month prospective study. Br J Ophthalmol. (2011) 95:335–9. 10.1136/bjo.2009.174284
    1. Sun L, Yao P, Li M, Shen Y, Zhao J, Zhou X. The safety and predictability of implanting autologous lenticule obtained by SMILE for hyperopia. J Refract Surg. (2015) 31:374–9. 10.3928/1081597X-20150521-03

Source: PubMed

3
Abonneren